|
2025
|
Invention
|
Methods of treating cancer with dll3 targeting radioimmunoconjugates. Described herein is a metho... |
|
|
Invention
|
Antibody linker conjugates. Described herein are novel linkers for use with immunoconjugates to c... |
|
|
Invention
|
Dll3 binding immunoconjugates and uses thereof. Described herein are heavy chain antibodies that ... |
|
2024
|
Invention
|
Polypeptide comprising a single-domain antibody variable region that binds delta-like ligand 3 (d... |
|
2023
|
Invention
|
Kidney targeting antibodies. Described herein are antibodies and immunoconjugates capable of targ... |
|
|
Invention
|
Dll3 binding molecules and uses thereof. Described herein are heavy chain antibodies that bind to... |
|
|
Invention
|
Multivalent immunoconjugates for targeted radioisotope therapy. Described herein are immunoconjug... |
|
|
Invention
|
Vhh antibody conjugates with heteroaryl chelators. Described herein are immunoconjugates comprisi... |
|
|
Invention
|
Vhh antibody conjugates. Described herein are immunoconjugates comprising an: a) antigen binding ... |
|
|
Invention
|
Vhh antibody dota conjugates. Described herein are immunoconjugates comprising an: a) antigen bin... |
|
|
Invention
|
Vhh antibody conjugates |
|
|
Invention
|
Vhh antibody dota conjugates |
|
|
Invention
|
Dll3 binding molecules and uses thereof |
|
|
Invention
|
Multivalent immunoconjugates for targeted radioisotope therapy |
|
|
Invention
|
Immunoconjugates for targeted radioisotope therapy.
Described herein are immunoconjugates compri... |
|
|
P/S
|
chemicals for pharmaceutical use, namely, for the treatment, prevention, or diagnosis of cancer; ... |
|
|
P/S
|
Chemicals for pharmaceutical use, namely, for the treatment, prevention, or diagnosis of cancer; ... |
|
2022
|
P/S
|
Pharmaceutical preparations for the treatment of cancer; Chemical preparations for the treatment,... |
|
|
Invention
|
Immunoconjugates for targeted radioisotope therapy. Described herein are immunoconjugates compris... |
